bioRxivBiophysicsPreprint
Nanobody-antigen catch-bond reveals NK cell mechanosensitivity
Cristina Gonzalez, Patrick ChamesiD, Brigitte Kerfelec, Daniel Baty, Philippe RobertiD, Laurent LimoziniD
Abstract
Antibodies are key tools in biomedical research and medicine. Their binding properties are classically measured in solution and characterized by an affinity. However, in physiological conditions, antibodies can bridge an immune effector cell and an antigen presenting cell, implying that mechanical forces apply to the bonds. For example, in antibody-dependent cell cytotoxicity, a major mode of action of therapeutic monoclonal antibodies, the Fab domains bind the antigens on the target cell, while the Fc domain binds to the activating receptor CD16 (also known as FcgRIII) of an immune effector cell, in a quasi bi-dimensional environment (2D). Therefore, there is a strong need to investigating antigen/antibody binding under force (2D), to better understand and predict antibody activity in vivo. We used two anti-CD16 nanobodies targeting two different epitopes and laminar flow chamber assay to measure the association and dissociation of single bonds formed between microsphere-bound CD16 antigens and surface-bound anti-CD16 nanobodies (or single domain antibodies), simulating 2D encounters. The two nanobodies exhibit similar 2D association kinetics, characterized by a strong dependence on the molecular encounter duration. However, their 2D dissociation kinetics strongly differ as a function of applied force: one exhibits a slip bond behaviour where off-rate increases with force; the other exhibits a catch bond behaviour with off-rate decreasing with force. This is the first time, to our knowledge, that catch bond behaviour was reported for antigen-antibody bond. We further exploit this property to show how Natural Killer cells spread differentially on surfaces coated with these molecules, revealing NK cells mechanosensitivity. Our results may also have strong implications for the design of efficient bispecific antibodies for therapeutic applications.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibody Fc receptor CD16a mediates natural killer cell activation via mechanotransduction of piconewton forces
Rong Ma, K. Christopher García, … Markus W. Covert·Science AdvancesPeer-reviewed·Aug 28, 2026
- The membrane distal domain of CD16a allosterically regulates NK cell ADCC
Tania Cid, Monica Fernandez-Quintéro, … Charles Daniel Murin·bioRxiv·Jul 6, 2026
- Decoupling individual host response and immune cell engager cytotoxic potency
Cristina Gonzàlez Gutierrez, Adrien Aimard, … Laurent Limozin·ACS NanoPeer-reviewed·Jan 10, 2025
- Mechanical Regulation of the Cytotoxic Activity of Natural Killer Cells
L. Mordechay, A. Edri, … G. Le Saux·bioRxiv·Mar 2, 2020
- A Proximity-Dependent Biosensor System for Visualizing Cell-Cell Interactions Induced by Therapeutic Antibodies
- Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain
Marie‐Pierre Valignat, Martine Biarnes‐Pelicot, … Philippe Robert·Integrative BiologyPeer-reviewed·Jan 1, 2026